| GBAP1 |
|
glucosylceramidase beta pseudogene 1
|
|
|
0.623 |
0.538 |
| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
| IBD2 |
|
inflammatory bowel disease 2
|
|
|
0.805 |
0.154 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| KIR2DL2 |
P43627
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
|
Receptor
|
|
0.612 |
0.654 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| RNASE2 |
P10153
|
ribonuclease A family member 2
|
|
|
0.621 |
0.692 |
| RNASE3 |
P12724
|
ribonuclease A family member 3
|
|
|
0.490 |
0.808 |
| RNU1-4 |
|
RNA, U1 small nuclear 4
|
|
|
0.626 |
0.577 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| MAP3K14 |
Q99558
|
mitogen-activated protein kinase kinase kinase 14
|
Kinase
|
|
0.608 |
0.769 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| RNU1-1 |
|
RNA, U1 small nuclear 1
|
|
|
0.608 |
0.731 |
| IBD3 |
|
inflammatory bowel disease 3
|
|
|
0.861 |
0.038 |
| IBD5 |
|
inflammatory bowel disease 5
|
|
|
0.705 |
0.538 |
| IBD6 |
|
inflammatory bowel disease 6
|
|
|
0.861 |
0.077 |
| IGF2-AS |
Q6U949
|
IGF2 antisense RNA
|
|
|
0.612 |
0.615 |
| DEFB103B |
P81534
|
defensin beta 103B
|
|
|
0.572 |
0.731 |
| MUC3B |
Q9H195
|
mucin 3B, cell surface associated
|
|
|
0.666 |
0.462 |
| IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
| NRAD1 |
|
non-coding RNA in the aldehyde dehydrogenase 1A pathway
|
|
|
0.792 |
0.192 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |